Aarti Pharmalabs Limited — Others, 10-05-2025: ESOP/ESOS/ESPS

Aarti Pharmalabs has announced a board meeting approving the grant of 42,000 stock options to select employees under its Performance Stock Option Plan 2023. Each option is exercisable at Rs. 5 and converts into one share of Rs. 5 face value. One-third of the options will vest annually over three years, based on continued employment and performance targets, with a three-year exercise window post-vesting. This move aims to align employee interests with the company’s growth, enhancing motivation and retention.